Stereospecific Construction of Propionates and Acetate–Propionates
COMMUNICATION
calcimycin,[18] while 19 has the correct relative and absolute
configuration of the C11–C22 unit of the anticancer macro-
lide dictyostatin.[19] Furthermore both building blocks are
propionate–deoxypropionate motifs. Thus, in addition to the
implementation of propionate construction these targets
allow simultaneously to demonstrate the flexible combina-
tion with a deoxypropionate structural motif that is encoun-
tered in many natural products of polyketide origin.
Thus, reaction of the Grignard reagent derived from bro-
mine 15 with (S)-2 and (R)-2 furnished the anti- and syn-de-
oxypropionates 16 and 17, respectively (Scheme 6). Depro-
tection, Sharpless epoxidation with (+)- or (À)-DET gave
the corresponding epoxides in excellent stereoselectivity. In-
troduction of the missing methyl group[20] occurred upon re-
[21]
action with Me2CuCNLi2
to give the desired diastereo-
meric propionate–deoxypopionate building blocks in excel-
lent yield and stereoselectivity. Furthermore, 18 was trans-
formed in three further steps[22] into the known thioacetal
20, which has served as an intermediate in a total synthesis
of calcimycin, thus representing a formal total synthesis.[23]
In conclusion, herein we have implemented a new and
unified strategy for the stereospecific and flexible construc-
tion of many major structural motifs of the polyketide class
of natural products relying on the o-DPPB-directed allylic
substitution with Grignard-derived organocopper reagents
as a key step. The key building block of this unified strategy
was the multifunctional allyl-o-DPPB ester 2. Both optical
antipodes are readily available by combining an enzymatic
cyanohydrin synthesis with a Mitsunobu inversion that em-
ploys the o-DPPBA as an unusual nucleophile. Thus, ace-
tate–deoxypropionates, acetate–propionates, and propio-
nates are readily available in enantiomerically pure form.
Hence, this strategy provides an interesting alternative to-
wards established aldol and enolate alkylation chemistry.
Scheme 5. Acetate–propionate construction. TBHP=tert-butyl hydroper-
oxide.
meric acetate–propionate building blocks are available ste-
reoselectively. This again highlights the stereochemical flexi-
bility of this strategy for acetate–propionate construction.
Based on a similar strategy propionates are accessible as
well. To implement the polypropionate synthesis strategy we
selected as targets the diastereomers 18 and 19 (Scheme 6).
The four stereogenic centers in 18 have the correct absolute
and relative configuration to those found for the ionophore
Experimental Section
General methods and further reactions are given in the Supporting Infor-
mation.
Representative procedure for the o-DPPB-directed allylic substitution:
Copper bromide dimethyl sulfide (196 mg, 0.95 mmol, 0.50 equiv) was
added in one portion to a solution of o-DPPB ester (S)-(À)-2 (1.20 g,
1.91 mmol, 99% ee) in diethyl ether (40 mL) and the resulting yellow sus-
pension was stirred for 10 min at room temperature. A solution of ethyl-
magnesium bromide (2.48 mL, 2.48 mmol, 1.30 equiv, 1m in diethyl ether)
was added over 15 min and the bright yellow suspension was stirred for a
further 3 h at room temperature. The reaction was quenched by succes-
sive addition of a saturated aqueous NH4Cl solution (10 mL) and an
aqueous ammonia solution (10 mL, 12.5%) followed by the addition of
diethyl ether (20 mL). The organic phase was separated and the aqueous
phase was extracted with three further portions of dichloromethane
(20 mL). The combined organic layers were dried over Na2SO4, and the
solvent was removed in vacuo. Column chromatography (cyclohexane/
ethyl acetate 10:1) furnished (R)-6 (578 mg, 1.64 mmol, 86%, 99% ee) as
a colorless oil. Analytical data for (R)-6: Chiral-GC: (deprotected allylic
alcohol): Hydrodex-b-TBDAc, 25.0 m
ꢄ 0.25 mm ꢄ 15 mm, injector:
Scheme 6. Propionate construction: Stereodivergent synthesis of a C14–
C20 building block 15 of the ionophore calcimycin, and a C11–C23 build-
ing block 14 of the macrolide dictyostatin.
2008C: 608C (isotherm), 0.7 mLminÀ1 He, (S)-4: tR =41.6 min, (R)-4: tR =
20
43.0 min; [a]D
:
À7.3 (c=1.5 in chloroform); 1H NMR (400 MHz,
CDCl3): d=0.87 (d, 3J(H,H)=7.4 Hz, 3H), 0.98 (d, 3J
ACTHNUTRGENNUG ACHUTTGNREN(NUGN H,H)=6.8 Hz,
Chem. Eur. J. 2009, 15, 6345 – 6348
ꢃ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6347